| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $128.6M | — | -5.1% |
| Cost of Revenue | $99.2M | — | +4.2% |
| Gross Profit | $29.4M | — | -27.0% |
| R&D Expense | $4.8M | — | +13.2% |
| SG&A Expense | $13.0M | — | +16.8% |
| Operating Income | $11.4M | — | -53.8% |
| Pre-tax Income | $9.7M | — | -57.4% |
| Income Tax | $2.4M | — | -35.7% |
| Net Income | $7.3M | — | -61.7% |
| EPS (Basic) | $0.32 | — | -61.4% |
| EPS (Diluted) | $0.32 | — | -61.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $45.1M | +9.3% | -9.9% |
| Accounts Receivable | $73.7M | -18.5% | -9.7% |
| Inventory | $129.2M | +1.5% | +10.7% |
| Current Assets | $274.8M | -5.5% | -1.2% |
| Total Assets | $430.7M | +1.4% | +15.5% |
| Current Liabilities | $80.4M | -12.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $19.1M | — | +117.1% |
| Capital Expenditures | $1.9M | — | -44.5% |
| Investing Cash Flow | -$13.8M | — | -305.6% |
| Financing Cash Flow | -$740K | — | +92.8% |
| Free Cash Flow | $17.2M | — | +218.8% |
| -66.4% |
| Long-term Debt | $5.0M | — | — |
| Total Liabilities | $244.9M | -0.5% | -15.1% |
| Stockholders' Equity | $185.8M | +4.0% | +120.3% |